The Vital Signs Monitors models VSM-300 and VSM-300A (hereinafter called monitor) are intended to be used for non-invasive continuous monitoring of SpO2 (oxygen saturation of the blood), NIBP (non-invasive blood pressure) and TEMP (temperature).

The monitors are intended to be used only under regular supervision of clinical personnel. It is applicable to adult, pediatric, and neonatal usage in hospitals, hospital type facilities and intra-hospital moves.

The monitors are equipped with alarms that indicate system faults (such as loose or defective electrodes), physiologic parameters that have exceeded the limits set by the operator, or both.

Device Description

VSM-300 & VSM-300A Vital Signs Monitors are patient monitoring devices providing the patient with a continuous vital physiological monitoring of noninvasive continuous monitoring of SpO2 (oxygen saturation of the blood), NIBP (non-invasive blood pressure) and TEMP (temperature) in a hospital, hospital type facilities environment and intra-hospital moves. The following lists the detailed features of the subject device.

· LCD or LED display
· SpO2, Pulse Rate NIBP and TEMP measurement
· Nellcor or EDAN SpO2 module
· Display numeric and waveform information simultaneously
· Nurse call feature
· Built-in Lithium-ion Battery
· Suitable for adult, pediatric and neonate patients
· Visual and audible alarm

AI/ML Overview

This 510(k) submission for the VSM-300 & VSM-300A Vital Signs Monitors does not contain the information requested in your prompt.

Here's a breakdown of why and what information is missing:

The provided text focuses on:

Administrative details: Device name, classification, submitter information, date prepared, 510(k) number.
Device description: What the device measures (SpO2, NIBP, TEMP), display type, features, and patient populations (adult, pediatric, neonate).
Intended Use: Reinforces the measurements and settings of use.
Non-clinical tests: Lists general categories like "Software testing," "Safety testing," "Performance testing," "Risk analysis," and "Final validation."
Predicate device comparison: States that the device is similar in technology and intended use to the predicate.
FDA correspondence: The official letter from the FDA determining substantial equivalence.

Crucially, it is missing all the detailed study information you requested, such as:

Specific acceptance criteria: The document only mentions "Performance testing" without detailing the specific thresholds or metrics being evaluated for NIBP, SpO2, or TEMP.
Reported device performance: There are no actual performance data (e.g., accuracy, bias, precision values) presented for any of the measured parameters.
Study design details:
- No mention of sample sizes for any test sets.
- No data provenance information (country, retrospective/prospective).
- No information on ground truth establishment (number of experts, qualifications, adjudication method, type of ground truth).
- No details about MRMC studies.
- No details about standalone algorithm performance (as this is a hardware device, not an AI/ML algorithm).
- No training set sample size or how its ground truth was established, as this is not an AI/ML device.

To answer your prompt, I would need a different type of document, typically a detailed test report or clinical study summary, that is often referenced or included as an appendix in a 510(k) submission, but is not present in the provided text.

Therefore, I cannot populate the table or answer the specific questions based on the input given.

This 510(k) summary is extremely high-level and does not delve into the granular details of performance validation studies.

Summary

{0}------------------------------------------------

1/3

510(k) Summary of Safety and Effectiveness

This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of 21 CFR 807.92.

The assigned 510(k) number is:

Submitter

Advanced Instrumentations, Inc. 6800 N.W. 77th Court Miami, Fl 33166 Telephone: 305-477-6331 Fax: 305-477-5351

Registration # 1066270

Official correspondent :

Jorge Millan, PhD Email: jmillan@hiatec.org 601 West 20 St Hialeah, FL 33010 Phone : (305) 925-1260

Date Prepared:

September 13, 2011

Device name and classification:

Device Name: VSM-300 & VSM-300A Vital Signs Monitors .
. Classification Name: Non-invasive blood pressure system, oximeter, clinical electronic thermometer
Product code: DQA, DXN, FLL .
. Regulatory Class: Class II

{1}------------------------------------------------

Predicate Device:

M3 & M3A Vital Signs Monitor K102835 Manufacturer: EDAN Instruments

Device Description:

· LCD or LED display
· SpO2, Pulse Rate NIBP and TEMP measurement
· Nellcor or EDAN SpO2 module
· Display numeric and waveform information simultaneously
· Nurse call feature
· Built-in Lithium-ion Battery
· Suitable for adult, pediatric and neonate patients
· Visual and audible alarm

Intended Use:

The Vital Signs Monitor models VSM-300 and VSM-300A (hereinafter called monitor) are intended to be used for non-invasive continuous monitoring of SpO2 (oxygen saturation of the blood), NIBP (non-invasive blood pressure) and TEMP (temperature).

The monitor is intended to be used only under reqular supervision of clinical personnel. It is applicable to adult, pediatric, and neonatal usage in hospitals, hospital type facilities and intra-hospital moves.

The monitor is equipped with alarms that indicate system faults (such as loose or defective electrodes), physiologic parameters that have exceeded the limits set by the operator, or both.

Effectiveness and Safety Contraindications:

Non-clinical test:

The following quality assurance measures were applied to the development of the Vital Signs Monitor Models VSM-300 & VSM-300A:

{2}------------------------------------------------

Software testing .
. Safety testing
. Performance testing
. Risk analvsis
Final validation .

Comparison to the predicate device:

The subject device has similar technology characteristics and has the same intended use as the predicate device. The VSM-300 & VSM-300A Vital Signs Monitor has the same characteristics as the predicate device cleared under K102835. Both models use the same technology and circuitry.

Substantially Equivalent Determination:

Verification and validation testing was done on the VSM-300 & VSM-300A Vital Signs Monitor. This premarket notification submission demonstrates that VSM-300 & VSM-300A Vital Signs Monitor is substantially equivalent to the predicate device.

{3}------------------------------------------------

Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo is a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" around the perimeter. Inside the circle is an abstract image of an eagle.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002

Advanced Instrumentations. Inc. c/o Jorge Millan, Ph.D. Executive Director 601 West 20 St Hialeah, FL 33010

1 4 2011 SEP

Re: K112465

Trade/Device Name: VSM-300 & VSM-300A Vital Signs Monitors Regulation Number: 21 CFR 870,2700 Regulation Name: Oximeter Regulatory Class: Class II (two) Product Code: DQA. DXN. FLL Dated: August 23, 2011 Received: August 26, 2011

Dear Dr. Millan:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent ffor the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA). it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

{4}------------------------------------------------

Page 2 - Jorge Millan, Ph.D.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801). please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm1 1 5809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/Reportal?roblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/industry/default.htm.

Sincerely yours,

Bram D. Tuckerman, M.D. Director/ Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{5}------------------------------------------------

Indications for Use

510(k) Number (if known):

Device Name:

VSM-300 & VSM-300A Vital Signs Monitor

Indications for Use:

The monitors are equipped with alarms that indicate system faults (such as loose or defective electrodes), physiologic parameters that have exceeded the limits set by the operator, or both.

Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR

Over-The-Counter Use (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Page 1 of ____________________________________________________________________________________________________________________________________________________________________

(Division Sign-Off)
Division of Cardiovascular Devices
510(k) Number K112465

Regulation Number and Section

§ 870.2700 Oximeter.

(a)
Identification. An oximeter is a device used to transmit radiation at a known wavelength(s) through blood and to measure the blood oxygen saturation based on the amount of reflected or scattered radiation. It may be used alone or in conjunction with a fiberoptic oximeter catheter.(b)
Classification. Class II (performance standards).